Experience

Novartis Nederland

• Netherlands
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• • Jan 2022 - Present

  Leading and accountable in the foundation of successful launches of (urticaria) products by building, sustaining and leveraging high-quality strategic partnerships throughout the lifecycle of innovative medicine. Providing medical-scientific and strategic expertise in clinical research, (pre-) marketing activities and scientific training of internal and external customers; Be accountable for the development, creating access to and launch of prioritized current and future Novartis products.

• • Aug 2017 - Feb 2022

  As a medical scientific liaison within dermatology (psoriasis, hidradenitis suppurativa & chronic spontaneous urticaria) in the South of the Netherlands I discuss with health care professionals within dermatology the most valuable scientific information and collaborate in useful projects to optimize the treatment for these patients. in these indications.Also a good collaboration internally with other medicals, market access and commercial results in valuable projects within dermatology to improve the patient care. Show less



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Global Medical Affairs Dermatology

  • Feb 2020 - Nov 2020

  Within the global medical affairs team preparing the pediatric psoriasis launch. Developing the medical pediatric psoriasis compendium including all important aspects of pediatrics and clinical data. Training the medicals within dermatology worldwide on the pediatric indication and treatment landscape. Co-lead in the GMAT pediatric psoriasis working group to shape the global and local strategy. Secondly, involved in the European Dermatology Congress and developing the medical booth and re-shape the content. Show less



Sanofi Genzyme

• Project associate scientific affairs

  • May 2016 - Aug 2017

  Working closely with medical affairs and marketing on diagnostic strategies within rare diseases as Gaucher, Pompe and Fabry. . Being responsible for projects as studying patient dynamics, trends and drivers to treatment starts and cessation. Develop algorithms for physicians to diagnose rare diseases. Working closely with medical affairs and marketing on diagnostic strategies within rare diseases as Gaucher, Pompe and Fabry. . Being responsible for projects as studying patient dynamics, trends and drivers to treatment starts and cessation. Develop algorithms for physicians to diagnose rare diseases.



Microbiome

• Netherlands
• Pharmaceutical Manufacturing

• Junior researcher

  • Mar 2016 - May 2016

  Technical and observational validation of a new implemented STI test in South Africa. In addition a market research of the health system of South Africa. Technical and observational validation of a new implemented STI test in South Africa. In addition a market research of the health system of South Africa.

• Regulatory Affairs Associate

  • Sep 2015 - Mar 2016

  Provided regulatory support to assigned products in the assigned markets: Middle-East, North-Africa and Eurasia and maintained awareness of applicable regulations in the region. Prepared and planed registration packages in line with local regulatory requirements and guidelines. Liaised and coordinated with affiliates to ensure timely submission of regulatory documents. Provided regulatory support to assigned products in the assigned markets: Middle-East, North-Africa and Eurasia and maintained awareness of applicable regulations in the region. Prepared and planed registration packages in line with local regulatory requirements and guidelines. Liaised and coordinated with affiliates to ensure timely submission of regulatory documents.



Vrije Universiteit Amsterdam

• Higher Education
• 1 - 100 Employee

• • Feb 2015 - Jul 2015

  The aim of this research was to investigate whether women with specific genetic markers are more likely to contract Neisseria gonorrhoeae infections. An additional observation was made whether women with Neisseria gonorrhoeae infection are more likely to Chlamydia trachomatis infection and thereby a double infection. Detection of genes related to the risk of Neisseria gonorrhoeae could be studied by looking to the relevance of functional single nucleotide polymorphisms (SNPs) in genes. Real-time PCR was used for detection of possible SNPs. Show less

• • Nov 2014 - Jul 2015

  A possible risk factor for preterm birth, miscarriage or IVF failure might be the composition of the vaginal microbiome (VMB) of the women. Articles and reviews from 1992 until 2015 using cultivation or molecular-dependent techniques for VMB detection were included in this review to provide an overview of the present knowledge about the influence of VMB at birth complications.



BIKASH, Green pasture Hosptial

• Internship: Psychosocial well-being of children with cerebral palsy and their parents in Nepal.

  • Feb 2014 - Jul 2014

  The aim of the study was to contribute to the psychosocial well-being of children with CP and their families by mapping out what kind of resources and services these families need, with special attention for differences between rural and urban areas in the region of Pokhara in Nepal. To gain more knowledge about what affects the psychosocial well-being was useful for designing successful interventions for disabled people and their family. A qualitative approach was done to explore the psychosocial well-being of children having CP and parents having a child with CP, and what their needs are. Show less



Netherlands Institute for Neuroscience

• Netherlands
• Research Services
• 100 - 200 Employee

• The role of Vitamin D in regulating HPA-axis and depression in Multiple sclerosis.

  • Mar 2013 - Jul 2014

  Low levels of CYP24A1 suggests a low bioavailability of vitamin D within a cell, and therefore a low exposure to vitamin D, which may result in a higher risk for depression. The aim of the study was whether there was a relation between CYP24A1 and CRH in MS patients and if this correlates to depression. Immunohistochemistry is used to double stain sections of hypothalamus for CRH and CYP24A1 from MS patients, with and without depression and control patients. The total expression of CYP24A and CRH in the PVN was measured and the localization of CYP24Ain CRH cells calculated using a Zeiss light microscope, Image J software and MATLAB. Show less